跳转至内容
Merck
CN
  • Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.

Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.

Bioorganic & medicinal chemistry letters (2009-05-08)
Liesbet Cosyn, Serge Van Calenbergh, Bhalchandra V Joshi, Hyojin Ko, Rhonda L Carter, T Kendall Harden, Kenneth A Jacobson
摘要

Ribose-based nucleoside 5'-diphosphates and triphosphates and related nucleotides were compared in their potency at the P2Y receptors with the corresponding nucleoside 5'-phosphonate derivatives. Phosphonate derivatives of UTP and ATP activated the P2Y(2) receptor but were inactive or weakly active at P2Y(4) receptor. Uridine 5'-(diphospho)phosphonate was approximately as potent at the P2Y(2) receptor as at the UDP-activated P2Y(6) receptor. These results suggest that removal of the 5'-oxygen atom from nucleotide agonist derivatives reduces but does not prevent interaction with the P2Y(2) receptor. Uridine 5'-(phospho)phosphonate as well as the 5'-methylenephosphonate equivalent of UMP were inactive at the P2Y(4) receptor and exhibited maximal effects at the P2Y(2) receptor that were 50% of that of UTP suggesting novel action of these analogues.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
腺苷 5′-三磷酸腺苷 (ATP) 二钠盐 水合物, vial of ~1 mg ATP